[Coagulative hemostasis in patients with acute viral myocarditis]

Likars'Ka Sprava
|January 17, 2009
PubMed

Insights

This study reveals that various blood markers, including fibrinogen parameters and platelet aggregation, correlate with the severity of acute virus myocarditis. These findings highlight the need for medication to correct these imbalances.

Area of Science:

  • Cardiology
  • Hematology
  • Virology

Context:

  • Acute virus myocarditis presents with complex pathophysiological changes.
  • Understanding these changes is crucial for effective patient management.
  • Existing literature lacks comprehensive correlation between specific hematological markers and myocarditis severity.

Purpose:

  • To investigate the correlation between a wide range of hematological and hemostatic parameters and the clinical severity of acute virus myocarditis.
  • To establish statistically reliable links between specific biomarkers and disease grades.

Summary:

  • This study established statistically significant correlations between fibrinogen parameters, dissolved complexes of monomeric fibrinogen (DCMF), fibrinogen/fibrin degradation products (FDP), platelet aggregation (first and second waves), activated partial thromboplastin time (APPT), range index of contact platelet activation (RICPA), general index of thrombophilia (GIT), platelet count, prothrombin time (PT), heparin in blood, plasma tolerance to heparin (PTH), euglobulin clot lysis time (TLEC), lipid peroxidation, antioxidant enzymes like superoxide dismutase (SOD), and the clinical severity of acute virus myocarditis.
  • These correlations were observed across three defined groups of disease severity.
  • The identified correlations indicate that these parameters are reliable indicators of disease progression and require therapeutic intervention.

Impact:

  • Provides novel insights into the hematological profile of acute virus myocarditis patients.
  • Establishes a basis for utilizing specific blood markers in assessing disease severity and guiding treatment strategies.
  • Suggests that targeted pharmacological correction of identified hematological abnormalities may improve patient outcomes in acute virus myocarditis.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...